Personalized blood biopsies may provide signal of cancer recurrence – Harvard Gazette
Does Ki-67 Predict Recurrence Risk in Early Stage Breast Cancer? | Physician's Weekly
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) | BMJ Open
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer - EBioMedicine
Monitoring breast cancer progression and response to therapy using... | Download Scientific Diagram
Tumor Marker - an overview | ScienceDirect Topics
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence | Clinical Cancer Research
Breast cancer
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time | British Journal of Cancer
Longterm Followup of Breast Cancer Patients Julie R
Patient monitoring of treatment response of her sixth breast cancer... | Download Scientific Diagram
PLOS ONE: Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
IJMS | Free Full-Text | Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer | HTML
Liquid Biopsy in Breast Cancer: A Comprehensive Review
Breast cancer biomarkers tag
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis | Journal of Comparative Effectiveness Research
Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing
Breast cancer biomarkers tag
Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer | Radiology
2-PREVENT Breast Cancer TCE | Penn Medicine | Philadelphia, PA
:max_bytes(150000):strip_icc()/breast-cancer-tumor-markers-and-tumor-marker-tests-4301102-30358af146c64584b345c51499c0d70c.png "Breast Cancer Tumor-Marker Tests")
Breast Cancer Tumor-Marker Tests
New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies | Clinical Cancer Research
Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis – results from a registry-based study from Germany | BMC Cancer | Full
PLOS ONE: Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
